SU1238732A3 - Способ получени 6-хлор-3-метил-2,3,4,5-тетрагидро-1 @ -3-бензазепина или его гидрохлорида - Google Patents

Способ получени 6-хлор-3-метил-2,3,4,5-тетрагидро-1 @ -3-бензазепина или его гидрохлорида Download PDF

Info

Publication number
SU1238732A3
SU1238732A3 SU823513948A SU3513948A SU1238732A3 SU 1238732 A3 SU1238732 A3 SU 1238732A3 SU 823513948 A SU823513948 A SU 823513948A SU 3513948 A SU3513948 A SU 3513948A SU 1238732 A3 SU1238732 A3 SU 1238732A3
Authority
SU
USSR - Soviet Union
Prior art keywords
chloro
hydrochloride
benzazepine
solution
rats
Prior art date
Application number
SU823513948A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Демаринис Роберт
Пол Хибл Джэкоб
Дэвид Мэтьюс Вильям
Original Assignee
Смитклайн Бекмэн Корпорейшн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бекмэн Корпорейшн (Фирма) filed Critical Смитклайн Бекмэн Корпорейшн (Фирма)
Application granted granted Critical
Publication of SU1238732A3 publication Critical patent/SU1238732A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SU823513948A 1981-11-27 1982-11-25 Способ получени 6-хлор-3-метил-2,3,4,5-тетрагидро-1 @ -3-бензазепина или его гидрохлорида SU1238732A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32524981A 1981-11-27 1981-11-27

Publications (1)

Publication Number Publication Date
SU1238732A3 true SU1238732A3 (ru) 1986-06-15

Family

ID=23267072

Family Applications (1)

Application Number Title Priority Date Filing Date
SU823513948A SU1238732A3 (ru) 1981-11-27 1982-11-25 Способ получени 6-хлор-3-метил-2,3,4,5-тетрагидро-1 @ -3-бензазепина или его гидрохлорида

Country Status (6)

Country Link
JP (1) JPS5892616A (cs)
KR (1) KR840002358A (cs)
CS (1) CS233740B2 (cs)
HU (1) HU190648B (cs)
SU (1) SU1238732A3 (cs)
ZA (1) ZA827887B (cs)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4541954A (en) * 1984-09-05 1985-09-17 Smithkline Beckman Corporation Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265890A (en) * 1978-07-07 1981-05-05 Smithkline Corporation 6-Phenyl thio- and 6-cyclohexyl thio-2,3,4,5-tetrahydro-1H-3-benzazepines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент US №.3752892, кл. 424-2444 1973. *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9102627B2 (en) 2003-06-17 2015-08-11 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8946207B2 (en) 2003-06-17 2015-02-03 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8404675B2 (en) 2003-06-17 2013-03-26 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8546378B2 (en) 2004-12-23 2013-10-01 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8802845B2 (en) 2006-04-03 2014-08-12 Arena Phamaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8501935B2 (en) 2006-04-03 2013-08-06 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US9770455B2 (en) 2010-09-01 2017-09-26 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
ZA827887B (en) 1983-11-30
HU190648B (en) 1986-09-29
KR840002358A (ko) 1984-06-25
CS233740B2 (en) 1985-03-14
JPS5892616A (ja) 1983-06-02

Similar Documents

Publication Publication Date Title
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
AT390257B (de) Verfahren zur herstellung neuer imidazo(4,5-b)chinolin-derivate
SU1238732A3 (ru) Способ получени 6-хлор-3-метил-2,3,4,5-тетрагидро-1 @ -3-бензазепина или его гидрохлорида
US3971783A (en) 4-Aminoquinazoline derivatives as cardiac stimulants
RU1779251C (ru) Способ получени 1-(4-аминофенил)-4-метил-7,8-метилендиокси-3,4-дигидро-5Н-2,3-бензодиазепина или его кислотно-аддитивных солей
JPH05186434A (ja) ４−ピリミジンカルボキサミド誘導体、その製造方法および治療への応用
JPH037264A (ja) ヒスタミン誘導体及びその製造方法並びに該誘導体を含有する医薬
US2831027A (en) Isocamphane compounds and processes for preparing the same
DE19604920A1 (de) Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
PL108111B1 (pl) Method of producing optically active antipodes of sposob wytwarzania optycznie czynnych antypodow n-n-/2-benzhydryloethylo/-n-/1-phenyloethylo/amines /2-benzhydryloetylo/-n-/1-fenyloetylo-/amin,i ich soli and salts thereof
JPH03141264A (ja) 強心活性およびベータ遮断活性を有するピリダジノン
US3682925A (en) ({31 )-di-o-isopropylidene-2-keto-l-gulonates
US5096900A (en) (4-piperidyl)methyl-2,3-dihydro-1h-isoindole and -2,3,4,5-tetrahydro-1h-benzazepine derivatives, their preparation and their application in therapy
KR920005827B1 (ko) 벤조티아디아제핀 유도체
US4598093A (en) 4-amino-tetrahydro-2-naphthoic acid derivatives
EP1444234A2 (de) Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel
JPS58116434A (ja) 置換されたフエノキシアルカノ−ルアミン類及びフエノキシアルカノ−ル−シクロアルキルアミン類
JPH02138263A (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
DE3223877C2 (cs)
CH636858A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
EP0146787B1 (de) Indolderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US3766188A (en) Carbonyldioxymorphinan derivatives
EP0257918A1 (en) Quinolone cardiac stimulants
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten